Early assessment of response to chemotherapy in lung cancer using dynamic contrast-enhanced MRI: A proof-of-concept study
Clinical Radiology Mar 27, 2018
Xu J, et al. - The early treatment response to chemotherapy was assessed by the experts in patients with lung cancer with the aid of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). It was reported that 13 responders after 1 week of chemotherapy illustrated a significant decrease in Ktrans and Ve compared with the pre-treatment value. Based on the results, it was found that DCE MRI could prove to be beneficial for the analysis of the early response to chemotherapy in patients with lung cancer.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries